Experts tie chemotherapy to slight increase in AML risk

02/14/2013 | HealthDay News

Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers faced an increased risk of developing acute myeloid leukemia, according to a new study. However, treatment was associated with lower AML risk in patients who had ovarian cancer, myeloma, and possibly lung cancer, researchers said. The findings appear in the journal Blood.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA